![Markus J. Cappel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus J. Cappel
Chairman at
OSE IMMUNOTHERAPEUTICS
Profile
Markus J.
Cappel currently works at OSE Immunotherapeutics SA, as Chairman from 2025.
Dr. Cappel also formerly worked at Millennium Pharmaceuticals, Inc., as Director-Business Development, Alkermes, Inc., as Vice President-Business Development from 1998 to 2001, Cygnus, Inc., as Principal, and ChemoCentryx, Inc., as Treasurer & Chief Business Officer from 2007 to 2022.
Dr. Cappel received his undergraduate degree and doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and Masters Business Admin degree from Harvard Business School.
Markus J. Cappel active positions
| Companies | Position | Start |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Chairman | 30/09/2025 |
Former positions of Markus J. Cappel
| Companies | Position | End |
|---|---|---|
| CHEMOCENTRYX, INC. | Corporate Officer/Principal | 18/10/2011 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Corporate Officer/Principal | 01/01/2001 |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Training of Markus J. Cappel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
- Stock Market
- Insiders
- Markus J. Cappel
